Related Experiment Videos
Rapid plasma digoxin assay in outpatients--a useful routine technique?
British Heart Journal
|September 1, 1985
Summary
For patients with atrial fibrillation, clinical assessment alone is sufficient for selecting digoxin dosage. Rapid plasma digoxin assay results rarely alter dosage decisions in outpatient settings.
Area of Science:
- Cardiology
- Clinical Pharmacology
Background:
- Digoxin is a common treatment for chronic atrial fibrillation.
- Plasma digoxin assays offer rapid results.
- Clinical assessment is the traditional method for digoxin dose selection.
Purpose of the Study:
- To evaluate the impact of rapid plasma digoxin assay results on dose selection in outpatients with atrial fibrillation.
- To determine if advanced assays improve upon clinical assessment for digoxin dosing.
Main Methods:
- Prospective study of 25 outpatients with chronic atrial fibrillation.
- Dose selection based on clinical assessment.
- Comparison with results from rapid plasma digoxin assays.
Main Results:
- Only one case out of 25 showed a dose alteration due to rapid assay results.
- No patients exhibited digoxin toxicity, even with renal impairment.
- Larger digoxin doses for uncontrolled ventricular rates were manageable via clinical assessment alone.
Conclusions:
- Simple clinical monitoring is adequate for selecting digoxin doses in most atrial fibrillation patients.
- Rapid digoxin assays have limited impact on outpatient dose adjustments.
- Clinical assessment remains a reliable method for digoxin management in atrial fibrillation.